HistoRx, Inc. Release: AQUA® Technology Uses Extend Beyond Protein: Effective Measurement of Messenger RNA Now Demonstrated
5/22/2012 10:52:52 AM
More...
|
HistoRx, Inc. Achieves Dominant Intellectual Property Position in Standardization of Results from Digital Pathology Instruments
2/29/2012 10:09:54 AM
More...
|
HistoRx, Inc. Earns Patent on Quantitative Immunoassay Optimization
2/22/2012 9:49:28 AM
More...
|
Clarient, Inc. Joins the HistoRx, Inc. Clinical Trials Network: First Commercial Lab to Provide Aqua(R) Technology for Clinical Trials
10/24/2011 2:18:16 PM
More...
|
HistoRx, Inc. Earns Two Additional Patents on Standardization of Results from Digital Pathology Instruments
10/7/2011 2:07:13 PM
More...
|
HistoRx, Inc. Announces Launch of New Research Services: AQUAPrep(TM) and Access AQUA(R) Services Now Available
5/3/2011 10:59:53 AM
More...
|
HistoRx, Inc. Receives Fundamental Patent on Standardization of Results In Digital Pathology
3/22/2011 9:24:43 AM
More...
|
Caliper Life Sciences, Inc. (CALP) and HistoRx, Inc. to Provide Integrated Solutions for Superior Protein Quantification of Biomarkers in Tissue
3/10/2011 7:15:41 AM
More...
|
Metamark Genetics, Inc. and HistoRx, Inc. Announce Licensing Agreement for AQUA(R) Technology
12/20/2010 9:13:11 AM
More...
|
Jack Davis, Diagnostics Industry Executive, Joins the HistoRx, Inc. Board of Directors
12/15/2010 11:13:53 AM
More...
|
|